FDA daily

FDA daily for Tuesday, February 24, 2026

In this issue: 18 approvals, 57 device recalls, 39 device decisions and 135 label changes. 3 items touch categories MedGrid carries, and they come first.

For MedGrid's categories

Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.

Drug and biologic approvals

FDA date:

On Tue, Feb 17 FDA approved 5 new applications (1 brand or biologic, 4 generic) and 13 supplements to existing ones.

  • SODIUM PHENYLBUTYRATE

    NAVINTA LLC · SODIUM PHENYLBUTYRATE

    ANDA220418Generic (ANDA)Prescription
  • COLCHICINE

    MICRO LABS · COLCHICINE

    ANDA212880Generic (ANDA)Prescription
  • MEDICAL AIR, USP

    INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC

    NDA221337Drug (NDA)Prescription
  • BOSENTAN

    ZYDUS PHARMS · BOSENTAN

    ANDA213981Generic (ANDA)Prescription
  • IDELALISIB

    NATCO · IDELALISIB

    ANDA216921Generic (ANDA)Discontinued
Browse drug and biologic approvals in FDA data →

Device recalls

FDA date:

FDA posted 57 device recalls from 5 firms on Tue, Feb 17.

Browse device recalls in FDA data →

Device clearances and approvals

FDA date:

FDA decided 11 510(k)s and 28 PMA decisions on Tue, Feb 10, including 1 original PMA.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

135 drug labels took effect on Tue, Feb 10; 2 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.

Browse label updates in FDA data →

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.